Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Transcatheter Embolization And Occlusion Devices Market Size, Share & Trends Analysis Report By Product (Coil, Non Coil), By Application (Peripheral Vascular Disease, Oncology, Neurology, Urology), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global transcatheter embolization and occlusion devices market are poised to reach an impressive USD 8.54 billion by 2030, registering a robust CAGR of 7.0% from 2023 to 2030. The market is showing remarkable growth, with a strong CAGR of 9.7% from 2019 to 2026, propelled by key drivers such as the increasing adoption of minimally invasive surgeries and the rising prevalence of cancer.
The demand for transcatheter embolization and occlusion (TEO) devices is further bolstered by their widespread use in treating conditions beyond cancer, such as vascular malformations and fibrosis. The introduction of technologically advanced products with enhanced efficiency is contributing significantly to the global market's growth trajectory. However, factors such as high costs, stringent regulatory approvals, and the requirement for skilled healthcare professionals to perform TEO procedures may pose challenges to market development.
Key Highlights of the Transcatheter Embolization And Occlusion Devices Market:
- Coils Dominate: Coils represent the largest share in the market, with a wide range of shapes and sizes available for different cases, making coiling a preferred treatment for embolization.
- Accessories Lead: The accessories segment is expected to be the largest type segment due to their extensive use across various modes of embolization and occlusion.
- North America and Europe Reign: In 2022, North America and Europe accounted for the largest market share, driven by advanced healthcare infrastructure, reimbursement coverage, and skilled professionals.
- Asia Pacific Soars: Asia Pacific is set to witness the highest CAGR from 2019 to 2026 due to increased healthcare expenditure, improved healthcare infrastructure, and rapid growth in medical tourism in emerging countries.
The global market for transcatheter embolization and occlusion devices is experiencing significant growth, with innovations in techniques and a surge in cancer cases driving demand. The Asia Pacific region is emerging as a high-growth hub, while North America and Europe continue to dominate the market. As advancements in healthcare treatments and products gain quick adoption, coupled with well-defined regulatory frameworks, the prospects for this market remain promising.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 210 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $4.82 Billion |
| Forecasted Market Value (USD) by 2030 | $8.54 Billion |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/mv0ij8
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
